Dr. Elizabeth Ramirez, MD

Dr. Ramirez practices at Jersey Women's Care Center, INC in Jersey City, New Jersey.

Dr. Ramirez's NPI, 1285716829, was assigned on October 20, 2006. Dr. Ramirez holds New York license 241943-1.

Dr. Ramirez's primary practice is Jersey Women's Care Center, INC, at 435 Central Ave, Jersey City, NJ 07307-2760. The practice phone is (201) 217-5600.

Dr. Ramirez's primary practice is Jersey Women's Care Center, INC in Jersey City, New Jersey. Dr. Ramirez is also affiliated with Jersey City Medical Center. The medical group on file is Jersey Women's Care Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ramirez practices, 2 sites in all. Vendor and product names are available with a free account.

Obstetrics and gynecology is Dr. Ramirez's primary specialty in the NPI Registry, under taxonomy code 207V00000X. Dr. Ramirez is licensed in New York.

CMS data shows 391 Medicare services from Dr. Ramirez across 6 procedure codes in 2024, for 91 Medicare patients. Medicare paid $29,260 for them. Every service was in an office.

CMS counts 91 Medicare patients who saw Dr. Ramirez in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ramirez's median patient age at 40, with 98% women.

In 2024, Dr. Ramirez wrote 327 Medicare Part D claims for 122 patients. 88% of them were for generic drugs. CMS names the drug for 229 of them, across 11 drugs with 11 or more claims each, at $7,507 in total drug cost. In 2023, CMS named 172 claims across 9 drugs.

Dr. Ramirez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Ramirez to 2 clinical trials. Conditions studied include Urethral Neoplasms and Urethral Diseases. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Ramirez that name 2 trials.

CMS Open Payments shows 242 general payments to Dr. Ramirez from 44 drug and device companies from 2016 to 2025. Education make up the largest share, 48% of the total. Intuitive Surgical, Inc. paid the most, $12,728. It also lists 2 research payments totaling $10,740 in 2017, naming 2 clinical trials.